Citius Pharmaceuticals Statistics
Total Valuation
CTXR has a market cap or net worth of $15.93 million. The enterprise value is $6.10 million.
| Market Cap | 15.93M |
| Enterprise Value | 6.10M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTXR has 27.45 million shares outstanding. The number of shares has increased by 154.35% in one year.
| Current Share Class | 27.45M |
| Shares Outstanding | 27.45M |
| Shares Change (YoY) | +154.35% |
| Shares Change (QoQ) | +16.95% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 4.79% |
| Float | 26.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.33 |
| Forward PS | 0.93 |
| PB Ratio | 0.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.09.
| Current Ratio | 0.84 |
| Quick Ratio | 0.34 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -82.51 |
Financial Efficiency
Return on equity (ROE) is -81.09% and return on invested capital (ROIC) is -47.02%.
| Return on Equity (ROE) | -81.09% |
| Return on Assets (ROA) | -26.57% |
| Return on Invested Capital (ROIC) | -47.02% |
| Return on Capital Employed (ROCE) | -63.32% |
| Weighted Average Cost of Capital (WACC) | 9.09% |
| Revenue Per Employee | $308,922 |
| Profits Per Employee | -$2.01M |
| Employee Count | 23 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.08 |
Taxes
In the past 12 months, CTXR has paid $189,923 in taxes.
| Income Tax | 189,923 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.22% in the last 52 weeks. The beta is 0.99, so CTXR's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -51.22% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 48.70 |
| Average Volume (20 Days) | 682,214 |
Short Selling Information
The latest short interest is 5.37 million, so 19.55% of the outstanding shares have been sold short.
| Short Interest | 5.37M |
| Short Previous Month | 5.16M |
| Short % of Shares Out | 19.55% |
| Short % of Float | 19.91% |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, CTXR had revenue of $7.11 million and -$46.27 million in losses. Loss per share was -$2.12.
| Revenue | 7.11M |
| Gross Profit | 5.50M |
| Operating Income | -57.37M |
| Pretax Income | -57.98M |
| Net Income | -46.27M |
| EBITDA | n/a |
| EBIT | -57.37M |
| Loss Per Share | -$2.12 |
Balance Sheet
The company has $17.01 million in cash and $7.18 million in debt, with a net cash position of $9.83 million or $0.36 per share.
| Cash & Cash Equivalents | 17.01M |
| Total Debt | 7.18M |
| Net Cash | 9.83M |
| Net Cash Per Share | $0.36 |
| Equity (Book Value) | 75.91M |
| Book Value Per Share | 2.43 |
| Working Capital | -8.32M |
Cash Flow
| Operating Cash Flow | -34.87M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 127,693 |
| Net Borrowing | 8.64M |
| Free Cash Flow | -34.87M |
| FCF Per Share | -$1.27 |
Margins
| Gross Margin | 77.34% |
| Operating Margin | -807.43% |
| Pretax Margin | -815.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CTXR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -154.35% |
| Shareholder Yield | -154.35% |
| Earnings Yield | -280.00% |
| FCF Yield | -210.98% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 26, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Nov 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
CTXR has an Altman Z-Score of -3.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.9 |
| Piotroski F-Score | 2 |